Beihai Gofar Marine Biological Industry Co Ltd (600538) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Beihai Gofar Marine Biological Industry Co Ltd (600538) has a cash flow conversion efficiency ratio of -0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-10.30 Million ≈ $-1.51 Million USD) by net assets (CN¥785.32 Million ≈ $114.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Beihai Gofar Marine Biological Industry (600538) market capitalisation for the company's overall valuation and market capitalisation.
Beihai Gofar Marine Biological Industry Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Beihai Gofar Marine Biological Industry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Beihai Gofar Marine Biological Industry Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beihai Gofar Marine Biological Industry Co Ltd ranked by their cash flow conversion efficiency. Explore 600538 cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shandong Cynda Chemcial Co Ltd
SHG:603086
|
-0.022x |
|
Dongwoon Anatech Co Ltd
KQ:094170
|
0.063x |
|
BP p.l.c
LSE:BP-B
|
0.103x |
|
Tianjin Motimo Membrane Tech
SHE:300334
|
-0.028x |
|
Shenzhen Prolto Supply Chain Management Co Ltd
SHE:002769
|
0.059x |
|
Kap Industrial Holdings Ltd
JSE:KAP
|
0.195x |
|
Aydem Yenilenebilir Enerji AS
IS:AYDEM
|
0.065x |
|
Beijing Capital International Airport Company Limited
F:BJ1
|
-0.023x |
Annual Cash Flow Conversion Efficiency for Beihai Gofar Marine Biological Industry Co Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Beihai Gofar Marine Biological Industry Co Ltd from 2001 to 2025. View Beihai Gofar Marine Biological Industry stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥700.78 Million ≈ $102.55 Million |
CN¥-13.40 Million ≈ $-1.96 Million |
-0.019x | -872.57% |
| 2024-12-31 | CN¥787.39 Million ≈ $115.22 Million |
CN¥1.95 Million ≈ $285.10K |
0.002x | +112.11% |
| 2023-12-31 | CN¥879.30 Million ≈ $128.67 Million |
CN¥-17.97 Million ≈ $-2.63 Million |
-0.020x | -24.61% |
| 2022-12-31 | CN¥959.98 Million ≈ $140.48 Million |
CN¥-15.74 Million ≈ $-2.30 Million |
-0.016x | -138.70% |
| 2021-12-31 | CN¥922.61 Million ≈ $135.01 Million |
CN¥-6.34 Million ≈ $-927.46K |
-0.007x | -121.79% |
| 2020-12-31 | CN¥851.56 Million ≈ $124.61 Million |
CN¥26.84 Million ≈ $3.93 Million |
0.032x | +473.92% |
| 2019-12-31 | CN¥645.61 Million ≈ $94.47 Million |
CN¥-5.44 Million ≈ $-796.48K |
-0.008x | +84.07% |
| 2018-12-31 | CN¥637.56 Million ≈ $93.30 Million |
CN¥-33.75 Million ≈ $-4.94 Million |
-0.053x | -196.61% |
| 2017-12-31 | CN¥659.18 Million ≈ $96.46 Million |
CN¥36.12 Million ≈ $5.29 Million |
0.055x | +302.99% |
| 2016-12-31 | CN¥688.79 Million ≈ $100.79 Million |
CN¥-18.59 Million ≈ $-2.72 Million |
-0.027x | -204.70% |
| 2015-12-31 | CN¥737.84 Million ≈ $107.97 Million |
CN¥-6.54 Million ≈ $-956.52K |
-0.009x | +84.25% |
| 2014-12-31 | CN¥729.59 Million ≈ $106.76 Million |
CN¥-41.05 Million ≈ $-6.01 Million |
-0.056x | -26.81% |
| 2013-12-31 | CN¥111.53 Million ≈ $16.32 Million |
CN¥-4.95 Million ≈ $-724.11K |
-0.044x | +83.13% |
| 2012-12-31 | CN¥91.60 Million ≈ $13.40 Million |
CN¥-24.09 Million ≈ $-3.52 Million |
-0.263x | -215.90% |
| 2011-12-31 | CN¥191.61 Million ≈ $28.04 Million |
CN¥-15.95 Million ≈ $-2.33 Million |
-0.083x | -27.56% |
| 2010-12-31 | CN¥225.47 Million ≈ $32.99 Million |
CN¥-14.71 Million ≈ $-2.15 Million |
-0.065x | -514.62% |
| 2009-12-31 | CN¥207.37 Million ≈ $30.34 Million |
CN¥-2.20 Million ≈ $-322.18K |
-0.011x | -119.93% |
| 2008-12-31 | CN¥325.43 Million ≈ $47.62 Million |
CN¥17.34 Million ≈ $2.54 Million |
0.053x | -38.36% |
| 2007-12-31 | CN¥492.89 Million ≈ $72.13 Million |
CN¥42.60 Million ≈ $6.23 Million |
0.086x | -51.04% |
| 2006-12-31 | CN¥529.39 Million ≈ $77.47 Million |
CN¥93.45 Million ≈ $13.67 Million |
0.177x | +3215.25% |
| 2005-12-31 | CN¥551.30 Million ≈ $80.67 Million |
CN¥2.94 Million ≈ $429.53K |
0.005x | -53.20% |
| 2004-12-31 | CN¥522.14 Million ≈ $76.41 Million |
CN¥5.94 Million ≈ $869.21K |
0.011x | +1364.46% |
| 2003-12-31 | CN¥478.86 Million ≈ $70.07 Million |
CN¥-430.83K ≈ $-63.04K |
-0.001x | -100.78% |
| 2002-12-31 | CN¥147.53 Million ≈ $21.59 Million |
CN¥17.01 Million ≈ $2.49 Million |
0.115x | -35.72% |
| 2001-12-31 | CN¥130.15 Million ≈ $19.05 Million |
CN¥23.35 Million ≈ $3.42 Million |
0.179x | -- |
About Beihai Gofar Marine Biological Industry Co Ltd
Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, distributes pharmaceutical products in China. It operates through Pharmaceutical Distribution; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails pharmaceutical products through hospitals, clinics, other medical institutions, phar… Read more